The decision by the European Medicines Agency (Coreper) on the AstraZeneca vaccine, the administration of which has been temporarily suspended, clarified the federal Ministry of Health.
“It clearly depends on the decision of Coreper. Clearly, Coreper’s decision is binding. “Clearly, we will follow the decision of Coreper, because it will decide whether the new data available from Germany and other European countries – let me remind you that in the meantime there is an eighth case of thrombosis in the brain – will affect the licensing of the vaccine.” said Health Ministry spokesman Hanno Kauts.
“In this sense, we will wait for it and decide further,” he added, noting that meetings of the Standing Vaccination Committee and the Paul Ehrlich Institute will follow.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
